Job Description
Our Organization
IONTAS is part of the FairJourney Biologics family, which operates across four global sites (Porto – Portugal, Cambridge – UK, San Francisco and San Diego – USA). FairJourney Biologics is dedicated to discovering high-quality biologics drug candidates for our partners, providing solutions to their technical challenges, and helping bring life-changing medicines to patients. Our antibody discovery and engineering services have benefitted over 200 biotech and pharma partners worldwide. With more than 1,000 completed projects using a range of molecular formats and 20 clinical-stage molecules, we are internationally recognized for tackling novel and challenging discovery programs. Our expertise in Phage and Mammalian Display platforms enables us to push the boundaries of antibody discovery, driving innovation for next-generation therapeutics.
The Role
We are seeking a highly capable and enthusiastic Senior Research Associate (SRA) to join our Discovery & Engineering Unit at our South Cambridgeshire site (DEU III).
This will be an onsite and predominantly lab-based role. Working within a project team, you will independently execute antibody discovery experiments for client projects, delivering first class results. You will apply your expertise to troubleshoot technical challenges as they arise and provide training to junior team members. Teamwork is a key skill for this role, as you will be collaborating with colleagues to plan and deliver project work. A positive and solution focused mindset is required to deliver on a wide range of innovative and intellectually challenging projects.
Key Responsibilities
Your Profile
Nice To Have:
We Offer
Be Part of a Global Team
By being part of the FairJourney Biologics family, you will be collaborating with teams in Porto, Cambridge, San Francisco and San Diego. You will have the opportunity to work alongside world-class scientists, share insights and contribute to ground breaking antibody projects.
Innovating the Future of Therapeutic Antibodies
IONTAS was co-founded in 2012 by John McCafferty, a pioneer of antibody phage display technology, which contributed to the 2018 Nobel Prize in Chemistry, and became part of the FairJourney Biologics family in 2020. By integrating phage and mammalian display expertise, we deliver high-affinity, developable antibodies that are shaping the future of drug discovery.
Career Development & Growth
As the biopharmaceutical industry continues to evolve, there is a growing reliance on specialized CROs to drive innovation in antibody discovery. With an increasing number of biotech and pharmaceutical companies outsourcing their research, FairJourney Biologics is well positioned for long-term growth and expanding opportunities.
Competitive Benefits
A Culture That Empowers
We foster an inclusive, collaborative environment where diverse perspectives are valued. At FairJourney Biologics, your ideas and contributions matter – helping us transform antibody discovery and deliver next-generation therapeutics.
If you're ready to take the next step in your career path, we’d love to hear from you!